Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.

South, Andrew M; Tomlinson, Laurie; Edmonston, Daniel; Hiremath, Swapnil; Sparks, Matthew A

South, Andrew M; Tomlinson, Laurie; Edmonston, Daniel; Hiremath, Swapnil; Sparks, Matthew A.

South AM; Section of Nephrology, Department of Pediatrics, Wake Forest School of Medicine and Brenner Children's Hospital, Winston Salem, NC, USA.
Tomlinson L; Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, NC, USA.
Edmonston D; Department of Surgery-Hypertension and Vascular Research, Wake Forest School of Medicine, Winston Salem, NC, USA.
Hiremath S; Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston Salem, NC, USA.
Sparks MA; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Nat Rev Nephrol ; 16(6): 305-307, 2020 06.

Article in English | MEDLINE | ID: covidwho-33746

Subject(s)

Betacoronavirus/drug effects; Coronavirus Infections/drug therapy; Enzyme Inhibitors/therapeutic use; Pneumonia, Viral/drug therapy; Renin-Angiotensin System/drug effects; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A/metabolism; SARS-CoV-2; Virus Internalization/drug effects; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Coronavirus Infections / Enzyme Inhibitors / Betacoronavirus Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: S41581-020-0279-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google